Cargando…

Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer

BACKGROUND: Colorectal cancer liver metastases (CRLM) has not been identified as a unified disease entity due to the differences in the severity of metastatic disease and tumor aggressiveness. A screen for specific prognostic risk subgroups is urgently needed. The current study aimed to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Jianhong, Li, Weihao, Fan, Wenhua, Zhang, Rongxin, Li, Xinyue, Xiao, Binyi, Dong, Yuejin, Wan, Desen, Pan, Zhizhong, Lin, Junzhong, Wu, Xiaojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542290/ https://www.ncbi.nlm.nih.gov/pubmed/34688293 http://dx.doi.org/10.1186/s12935-021-02250-x

Ejemplares similares

Application of Tumor Burden Score for predicting conversion outcome in patients with initially unresectable colorectal liver metastases after first-line systemic therapy
por: Peng, Jianhong, et al.
Publicado: (2021)

Liver surgery prolongs the survival of patients with gastrointestinal stromal tumor liver metastasis: a retrospective study from a single center
por: Xiao, Binyi, et al.
Publicado: (2018)

Hepatitis B Virus Infection Predicts Better Survival In Patients With Colorectal Liver-only Metastases Undergoing Liver Resection
por: Zhao, Yujie, et al.
Publicado: (2018)

Efficacy and safety of neoadjuvant imatinib therapy for patients with locally advanced rectal gastrointestinal stromal tumors: A multi-center cohort study
por: Li, Weihao, et al.
Publicado: (2022)

Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer
por: Xiao, Binyi, et al.
Publicado: (2017)

Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastases
por: Liao, Leen, et al.
Publicado: (2023)

Serum Gamma Glutamyl transferase is a predictor of recurrence after R0 hepatectomy for patients with colorectal cancer liver metastases
por: Xiao, Binyi, et al.
Publicado: (2020)

Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival
por: Peng, Jianhong, et al.
Publicado: (2017)

Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience
por: Peng, Jianhong, et al.
Publicado: (2019)

Surgical Outcomes of Robotic Resection for Sigmoid and Rectal Cancer: Analysis of 109 Patients From a Single Center in China
por: Peng, Jianhong, et al.
Publicado: (2021)

Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?
por: Pan, Zhizhong, et al.
Publicado: (2018)

Efficacy and safety of a NiTi CAR 27 compression ring for end-to-end anastomosis compared with conventional staplers: A real-world analysis in Chinese colorectal cancer patients
por: Lu, Zhenhai, et al.
Publicado: (2016)

The Pathologic Complete Response Ratio of Liver Metastases Represents a Valuable Prognostic Indicator
por: Xu, Yanbo, et al.
Publicado: (2022)

Does the Preoperative Prognostic Nutritional Index Predict Survival in Patients with Liver Metastases from Colorectal Cancer Who Underwent Curative Resection?
por: Zhao, Yujie, et al.
Publicado: (2018)

Prognostic value of tumor infiltrating lymphocytes combined with PD-L1 expression for patients with solitary colorectal cancer liver metastasis
por: Xiao, Binyi, et al.
Publicado: (2020)

Immune Cell Infiltration in the Microenvironment of Liver Oligometastasis from Colorectal Cancer: Intratumoural CD8/CD3 Ratio Is a Valuable Prognostic Index for Patients Undergoing Liver Metastasectomy
por: Peng, Jianhong, et al.
Publicado: (2019)

Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer
por: Peng, Jianhong, et al.
Publicado: (2017)

Addition of oxaliplatin to capecitabine-based preoperative chemoradiotherapy for locally advanced rectal cancer: Long-term outcome of a phase II study
por: Peng, Jianhong, et al.
Publicado: (2017)

Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
por: Peng, Jianhong, et al.
Publicado: (2020)

Preoperative AFU Is a Useful Serological Prognostic Predictor for Colorectal Liver Oligometastasis Patients Undergoing Hepatic Resection
por: Deng, Yuxiang, et al.
Publicado: (2019)

TROP2 overexpression in colorectal liver oligometastases is associated with poor prognosis after liver resection
por: Peng, Jianhong, et al.
Publicado: (2019)

Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial
por: Wang, Fulong, et al.
Publicado: (2018)

Expression of voltage-gated sodium channel Nav1.5 in non-metastatic colon cancer and its associations with estrogen receptor (ER)-β expression and clinical outcomes
por: Peng, Jianhong, et al.
Publicado: (2017)

Local surgical excision versus endoscopic resection for rectal carcinoid: A meta-analysis.
por: Sui, Qiaoqi, et al.
Publicado: (2017)

Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancer
por: Peng, Jianhong, et al.
Publicado: (2016)

High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy
por: Zhou, Wenhao, et al.
Publicado: (2019)

Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection
por: Peng, Jianhong, et al.
Publicado: (2018)

The development and initial validation of the Health and Reproductive Survey (HeRS)
por: Duffy, Donna, et al.
Publicado: (2021)

Conversion therapy with the intent to perform radical local treatment may not be suitable for patients with 10 or more liver metastases from colorectal cancer
por: Lin, Junzhong, et al.
Publicado: (2022)

MiR-1307-5p targeting TRAF3 upregulates the MAPK/NF-κB pathway and promotes lung adenocarcinoma proliferation
por: Du, Xinyue, et al.
Publicado: (2020)

Long-Term Outcome of Oxaliplatin and Capecitabine (XELOX) Concomitant with Neoadjuvant Radiotherapy and Extended to the Resting Period in High Risk Locally Advanced Rectal Cancer
por: Tang, Jinghua, et al.
Publicado: (2018)

Ploidy dynamics increase the risk of liver cancer initiation
por: Müller, Miryam, et al.
Publicado: (2021)

Lymph node ratio as a valuable prognostic factor for patients with colorectal liver-only metastasis undergoing curative resection
por: Deng, Yuxiang, et al.
Publicado: (2018)

Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis
por: Zhang, Yuanping, et al.
Publicado: (2020)

Expression of a novel CNPY2 isoform in colorectal cancer and its association with oncologic prognosis
por: Peng, Jianhong, et al.
Publicado: (2017)

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

microRNA-338-3p inhibits proliferation, migration, invasion, and EMT in osteosarcoma cells by targeting activator of 90 kDa heat shock protein ATPase homolog 1
por: Cao, Riliang, et al.
Publicado: (2018)

The structure of blood–tumor barrier and distribution of chemotherapeutic drugs in non-small cell lung cancer brain metastases
por: Ye, Ling-yun, et al.
Publicado: (2021)

Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases
por: Fassan, Matteo, et al.
Publicado: (2018)

Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
por: Chen, Wanghua, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pcprusl17017pk81ik8op7tq3s